Toggle Side Panel
Close search

Friedreich’s Ataxia News Community › Forums › Research, Science, and Trials › First FA Patients to Receive Leriglitazone in Ongoing FRAMES Trial

  • Research, Science, and Trials

    First FA Patients to Receive Leriglitazone in Ongoing FRAMES Trial

    Posted by Community Member on June 24, 2019 at 10:28 am

    Researchers have started dosing patients with Minoryx Therapeutics’ leriglitazone in the ongoing Phase 2 FRAMES trial in patients with Friedreich’s ataxia. Read more about the trial here.

    What do you think of this news?

    replied 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .